{"entity":{"type":"insider","cik":"0001642355","url":"/insider/0001642355","json_url":"/insider/0001642355.json","name":"Braslyn Ltd.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":64,"n_filings":18,"first":"2016-03-22","last":"2021-03-10","span_basis":"filed_date"},"name_variants":[{"name":"Braslyn Ltd.","source":"filing","n_filings":18,"first_seen":"2016-03-22","last_seen":"2021-03-10"}],"transactions":[{"id":4305164,"accession":"0000899243-21-011086","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-21-011086","line_url":"/filing/0000899243-21-011086","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Braslyn Ltd.; LEWIS JOSEPH","owner_display_name":"Braslyn Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":410.0,"shares_display":"410","price_per_share":196.7599512195122,"price_display":"196.76","price_state":"stated","total_value":80671.58,"total_display":"80,671.58","total_whole":"80,672","shares_owned_after":3135557.0,"shares_owned_after_display":"3,135,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-10","filed_date":"2021-03-10","scope":"insider","n_lines":4},{"id":4305143,"accession":"0000899243-21-011086","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-011086","line_url":"/filing/0000899243-21-011086","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Braslyn Ltd.; LEWIS JOSEPH","owner_display_name":"Braslyn Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11971.0,"shares_display":"11,971","price_per_share":197.66535210091052,"price_display":"197.67","price_state":"stated","total_value":2366251.93,"total_display":"2,366,251.93","total_whole":"2,366,252","shares_owned_after":3130226.0,"shares_owned_after_display":"3,130,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-09","filed_date":"2021-03-10","scope":"insider","n_lines":5},{"id":2992521,"accession":"0000899243-20-034137","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-034137","line_url":"/filing/0000899243-20-034137#line-4","is_derivative":false,"issuer_cik":"0001022652","issuer_name":"INSEEGO CORP.","issuer_ticker":"INSG","issuer_name_source":null,"issuer_url":"/issuer/0001022652","owner_cik":"0001642355","owner_name":"Braslyn Ltd.","owner_display_name":"Braslyn Ltd.","owner_url":"/insider/0001642355","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":293848.0,"shares_display":"293,848","price_per_share":14.3749,"price_display":"14.37","price_state":"stated","total_value":4224035.6152,"total_display":"4,224,035.62","total_whole":"4,224,036","shares_owned_after":7614830.0,"shares_owned_after_display":"7,614,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-16","scope":"insider"},{"id":2992518,"accession":"0000899243-20-034137","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-034137","line_url":"/filing/0000899243-20-034137#line-3","is_derivative":false,"issuer_cik":"0001022652","issuer_name":"INSEEGO CORP.","issuer_ticker":"INSG","issuer_name_source":null,"issuer_url":"/issuer/0001022652","owner_cik":"0001642355","owner_name":"Braslyn Ltd.","owner_display_name":"Braslyn Ltd.","owner_url":"/insider/0001642355","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":190590.0,"shares_display":"190,590","price_per_share":14.8077,"price_display":"14.81","price_state":"stated","total_value":2822199.543,"total_display":"2,822,199.54","total_whole":"2,822,200","shares_owned_after":7908678.0,"shares_owned_after_display":"7,908,678","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-16","scope":"insider"},{"id":2992514,"accession":"0000899243-20-034137","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-034137","line_url":"/filing/0000899243-20-034137","is_derivative":false,"issuer_cik":"0001022652","issuer_name":"INSEEGO CORP.","issuer_ticker":"INSG","issuer_name_source":null,"issuer_url":"/issuer/0001022652","owner_cik":"0001642355","owner_name":"Braslyn Ltd.","owner_display_name":"Braslyn Ltd.","owner_url":"/insider/0001642355","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900732.0,"shares_display":"1,900,732","price_per_share":15.661007556825476,"price_display":"15.66","price_state":"stated","total_value":29767378.2155,"total_display":"29,767,378.22","total_whole":"29,767,378","shares_owned_after":8278217.0,"shares_owned_after_display":"8,278,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider","n_lines":2},{"id":2785090,"accession":"0000899243-20-030059","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0000899243-20-030059","line_url":"/filing/0000899243-20-030059","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Braslyn Ltd.; LEWIS JOSEPH","owner_display_name":"Braslyn Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104564.0,"shares_display":"104,564","price_per_share":213.33242260625073,"price_display":"213.33","price_state":"stated","total_value":22306891.4374,"total_display":"22,306,891.44","total_whole":"22,306,891","shares_owned_after":3057226.0,"shares_owned_after_display":"3,057,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-29","filed_date":"2020-10-30","scope":"insider","n_lines":16},{"id":2785016,"accession":"0000899243-20-030059","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-20-030059","line_url":"/filing/0000899243-20-030059","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Braslyn Ltd.; LEWIS JOSEPH","owner_display_name":"Braslyn Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":295436.0,"shares_display":"295,436","price_per_share":206.56773657238793,"price_display":"206.57","price_state":"stated","total_value":61027545.822,"total_display":"61,027,545.82","total_whole":"61,027,546","shares_owned_after":3006568.0,"shares_owned_after_display":"3,006,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-28","filed_date":"2020-10-30","scope":"insider","n_lines":9},{"id":3276490,"accession":"0000899243-20-019894","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-019894","line_url":"/filing/0000899243-20-019894#line-3","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Pandion Therapeutics, Inc.","issuer_ticker":"PAND","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Capital, LLC; Braslyn Ltd.; LEWIS JOSEPH; Davis Aaron I.; Boxer Asset Management Inc.; MVA Investors, LLC","owner_display_name":"Boxer Capital, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":722222.0,"shares_display":"722,222","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":12999996.0,"total_display":"12,999,996.00","total_whole":"12,999,996","shares_owned_after":2107513.0,"shares_owned_after_display":"2,107,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-21","filed_date":"2020-07-21","scope":"insider"},{"id":9204733,"accession":"0000899243-20-016700","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-016700","line_url":"/filing/0000899243-20-016700#line-1","is_derivative":false,"issuer_cik":"0001642355","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001642355","owner_cik":"0001642355","owner_name":"Braslyn Ltd.","owner_display_name":"Braslyn Ltd.","owner_url":"/insider/0001642355","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600000.0,"shares_display":"600,000","price_per_share":97.0,"price_display":"97.00","price_state":"stated","total_value":58200000.0,"total_display":"58,200,000.00","total_whole":"58,200,000","shares_owned_after":2535966.0,"shares_owned_after_display":"2,535,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-12","filed_date":"2020-06-16","scope":"insider"},{"id":3033016,"accession":"0000899243-20-016664","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-016664","line_url":"/filing/0000899243-20-016664#line-3","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001642355","owner_name":"Braslyn Ltd.","owner_display_name":"Braslyn Ltd.","owner_url":"/insider/0001642355","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600000.0,"shares_display":"600,000","price_per_share":69.0,"price_display":"69.00","price_state":"stated","total_value":41400000.0,"total_display":"41,400,000.00","total_whole":"41,400,000","shares_owned_after":2535966.0,"shares_owned_after_display":"2,535,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-12","filed_date":"2020-06-16","scope":"insider"},{"id":7991634,"accession":"0000899243-19-006351","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-006351","line_url":"/filing/0000899243-19-006351#line-3","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001642355","owner_name":"Braslyn Ltd.","owner_display_name":"Braslyn Ltd.","owner_url":"/insider/0001642355","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":275000.0,"shares_display":"275,000","price_per_share":69.0,"price_display":"69.00","price_state":"stated","total_value":18975000.0,"total_display":"18,975,000.00","total_whole":"18,975,000","shares_owned_after":2860966.0,"shares_owned_after_display":"2,860,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-05","scope":"insider"},{"id":4647218,"accession":"0000899243-17-026986","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-026986","line_url":"/filing/0000899243-17-026986","is_derivative":false,"issuer_cik":"0001465837","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001465837","owner_cik":null,"owner_name":"Braslyn Ltd.; Boxer Capital, LLC","owner_display_name":"Braslyn Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":5200000.0,"total_display":"5,200,000.00","total_whole":"5,200,000","shares_owned_after":3135966.0,"shares_owned_after_display":"3,135,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-16","filed_date":"2017-11-20","scope":"insider","n_lines":2},{"id":4808125,"accession":"0000899243-17-002188","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-002188","line_url":"/filing/0000899243-17-002188","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001642355","owner_name":"Braslyn Ltd.","owner_display_name":"Braslyn Ltd.","owner_url":"/insider/0001642355","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":48169.0,"shares_display":"48,169","price_per_share":5.445987045610247,"price_display":"5.45","price_state":"stated","total_value":262327.75,"total_display":"262,327.75","total_whole":"262,328","shares_owned_after":2880702.0,"shares_owned_after_display":"2,880,702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-26","filed_date":"2017-01-30","scope":"insider","n_lines":2},{"id":4522616,"accession":"0000899243-17-001947","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-17-001947","line_url":"/filing/0000899243-17-001947#line-3","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001642355","owner_name":"Braslyn Ltd.","owner_display_name":"Braslyn Ltd.","owner_url":"/insider/0001642355","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30600.0,"shares_display":"30,600","price_per_share":5.42,"price_display":"5.42","price_state":"stated","total_value":165852.0,"total_display":"165,852.00","total_whole":"165,852","shares_owned_after":2832533.0,"shares_owned_after_display":"2,832,533","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-25","filed_date":"2017-01-25","scope":"insider"},{"id":4522608,"accession":"0000899243-17-001947","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-001947","line_url":"/filing/0000899243-17-001947#line-2","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001642355","owner_name":"Braslyn Ltd.","owner_display_name":"Braslyn Ltd.","owner_url":"/insider/0001642355","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27682.0,"shares_display":"27,682","price_per_share":5.32,"price_display":"5.32","price_state":"stated","total_value":147268.24,"total_display":"147,268.24","total_whole":"147,268","shares_owned_after":2801933.0,"shares_owned_after_display":"2,801,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-24","filed_date":"2017-01-25","scope":"insider"},{"id":4522598,"accession":"0000899243-17-001947","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-001947","line_url":"/filing/0000899243-17-001947#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001642355","owner_name":"Braslyn Ltd.","owner_display_name":"Braslyn Ltd.","owner_url":"/insider/0001642355","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19251.0,"shares_display":"19,251","price_per_share":5.27,"price_display":"5.27","price_state":"stated","total_value":101452.77,"total_display":"101,452.77","total_whole":"101,453","shares_owned_after":2774251.0,"shares_owned_after_display":"2,774,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-23","filed_date":"2017-01-25","scope":"insider"},{"id":4767612,"accession":"0000899243-17-001652","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-17-001652","line_url":"/filing/0000899243-17-001652#line-3","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001642355","owner_name":"Braslyn Ltd.","owner_display_name":"Braslyn Ltd.","owner_url":"/insider/0001642355","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23873.0,"shares_display":"23,873","price_per_share":5.42,"price_display":"5.42","price_state":"stated","total_value":129391.66,"total_display":"129,391.66","total_whole":"129,392","shares_owned_after":2755000.0,"shares_owned_after_display":"2,755,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-20","filed_date":"2017-01-20","scope":"insider"}],"collapsed":true,"next_cursor":"2017-01-20|4767612","ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":20,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Ten percent owner","n_filings":16,"first_seen":"2016-03-22","last_seen":"2021-03-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001022652","name":"INSEEGO CORP.","url":"/issuer/0001022652","role":"Ten percent owner","n_filings":1,"first_seen":"2020-12-16","last_seen":"2020-12-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001807901","name":"Pandion Therapeutics, Inc.","url":"/issuer/0001807901","role":"Ten percent owner","n_filings":1,"first_seen":"2020-07-21","last_seen":"2020-07-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001642355","retrieved_at":"2026-08-22T23:05:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}